Interleukin Related Inhibitors

IL-1

IL-2

IL-3

IL-4

IL-5

IL-6

IL-8

IL-10

IL-12

IL-13

IL-15

IL-17

IL-23

IL-7

IL-33

IL-22

Interleukin Related Inducers, Inhibitors, Agonists, Antagonists, Activators & Modulators

Product Name	IL-1	IL-2	IL-3	IL-4	IL-5	IL-6	IL-8	IL-10	IL-12	IL-13	IL-15	IL-17	IL-23	IL-7	IL-33	IL-22	Purity
Resatorvid						IL-6, IC₅₀: 1.3 nM											99.95%
Disulfiram	IL-1β																99.92%
Polyinosinic-polycytidylic acid										IL-13		IL-17A					99.40%
Raleukin	IL-1																99.40%
Deucravacitinib									IL-12				IL-23				99.87%
Icotrokinra													IL-23, Kd: 7.1 pM				99.89%
S7						IL-6											99.12%
Dupilumab		IL-2		IL-4						IL-13							≥99.2%
Oxidopamine hydrobromide	IL-1β																99.95%
Tocilizumab						IL-6											99.67%
Apilimod				IL-4	IL-5		IL-8		IL-12				IL-23				99.56%
Oxidopamine hydrochloride	IL-1β																99.91%
LMT-28						IL-6											98.93%
Theophylline						IL-6		IL-10									99.89%
Secukinumab												IL-17A					≥99.20%
Sodium metatungstate	IL-1β
Benzbromarone	IL-1β						IL-8										99.81%
Hydrocortisone hemisuccinate			IL-3, IC₅₀: 21.4 μM			IL-6, IC₅₀: 6.7 μM											99.76%
SC144						IL6-beta											98.50%
LY3509754												IL-17					99.65%
ODN 2216									IL-12
Muscone	IL-1β					IL-6											≥98.0%
Ixekizumab												IL-17					98.90%
Apilimod mesylate				IL-4	IL-5		IL-8		IL-12				IL-23				99.83%
Fibrinogen (Bovine)							IL-8
Risankizumab													IL-23, Kd: <10 pM				99.37%
JTE-607						IL-6	IL-8	IL-10									99.27%
Ustekinumab									IL-12				IL-23				98.42%
APY0201									IL-12				IL-23				99.93%
Diacerein	IL-1β																98.78%
Lysophosphatidylcholines	IL-1β																≥99.0%
IL-17A antagonist 1												IL-17A, IC₅₀: 1.14 nM IL-17A, Kd: 0.66 μM					99.74%
Bimekizumab												IL-17A IL-17F
Oxazolone				IL-4						IL-13							≥98.0%
Vidofludimus												IL-17					99.11%
Semapimod tetrahydrochloride	IL-1β					IL-6											98.43%
Mulberroside A	IL-1β					IL-6											99.86%
Diallyl Trisulfide						IL-6	IL-8
Prednisone acetate				IL-4				IL-10				IL-17					99.44%
Lebrikizumab										IL-13							99.90%
Tryptanthrin		IL-2				IL-6		IL-10	IL-12								99.89%
Guselkumab													IL-23, IC₅₀: .06 nM				98.97%
Neochlorogenic acid	IL-1β																99.77%
Astegolimab															ST2
Golimumab	IL-1					IL-6											99.68%
Y-320											IL-15	IL-17					99.74%
AF12198	IL1R1, IC₅₀: 8 nM																99.75%
Smurf1-IN-A01	IL-1β																99.81%
IL-17 modulator 4												IL-17					98.18%
Daclizumab		IL-2
AX-024						IL-6		IL-10				IL-17A					99.29%
Deltamethrin	IL-1β																99.93%
BRD6989								IL-10									99.56%
Broussonin E	IL-1β					IL-6		IL-10									98.18%
Inbakicept											IL-15Rα						98.95%
Sarilumab						IL-6											98.37%
Ginsenoside Rc	IL-1β																≥98.0%
Peimine	IL-1 IL-1β					IL-6		IL-10									99.40%
Elobixibat						IL-6											99.91%
Ginsenoside Rh1	IL-1β					IL-6											≥98.0%
Thiabendazole	IL-1β					IL-6		IL-10		IL-13							99.77%
Madecassic acid	IL-1β					IL-6											99.23%
Tralokinumab										IL-13
SC144 hydrochloride						IL6-beta											99.34%
Veledimex	IL-1								IL-12								98.45%
Lipoxin A4						IL-6	IL-8										≥98.0%
NecroX-7						IL-6											99.69%
Ossirene	IL-1β					IL-6	IL-8	IL-10									≥98.0%
Ac-YVAD-CHO	IL-1β																98.97%
RCGD423						IL6-beta											99.66%
Pectolinarin						IL-6	IL-8										99.89%
Elsilimomab						IL-6, IC₅₀: 1.4 nM
YQ128	IL-1β																99.83%
Nidanilimab (Nadunolimab)	IL-1α IL-1β																99.90%
Lusvertikimab														IL7R			99.41%
UF010						IL-6											99.84%
IL-15-IN-1											IL-15, IC₅₀: 0.8 μM						99.42%
Elubrixin tosylate							IL-8										99.78%
IL-17A modulator-1												IL-17A, pIC₅₀: 8.2					99.01%
Pinostrobin	IL-1β																99.98%
Reslizumab					IL-5, IC₅₀: 91.1 pM												99.40%
VGX-1027	IL-1β							IL-10									99.76%
Taurohyodeoxycholic acid sodium						IL-6											99.60%
AX-024 hydrochloride						IL-6		IL-10				IL-17A					99.75%
IL-17 modulator 3												IL-17 IL-17					99.53%
Etokimab			IL-3														99.90%
Sonelokimab												IL-17A IL-17F					≥99.0%
Kaempferol 3-O-β-D-glucuronide	IL-1β							IL-10									99.41%
Benralizumab					IL-5Rα												≥99.1%
RO2959 monohydrochloride		IL-2															98.21%
Olokizumab						IL-6
Ordesekimab											IL-15
Gamma-glutamylcysteine TFA	IL-1β					IL-6		IL-10
YM-90709					IL-5												99.77%
Nepetin	IL-1					IL-6	IL-8										99.51%
Ginsenoside F3		IL-2		IL-4				IL-10									99.84%
Rilonacept	IL-1
Cendakimab										IL-13							99.96%
N-Acetyl-L-tryptophan	IL-1β																99.38%
Armillarisin A	IL-1β			IL-4													99.80%
Briakinumab									IL-12				IL-23
SP4206		IL-2, Kd: 70 nM															98.55%
Naphazoline hydrochloride	IL-1β			IL-4		IL-6											98.37%
Balsalazide	IL-1					IL-6											99.34%
Fosfenopril	IL-1β					IL-6											99.89%
iNOs-IN-1						IL-6											99.83%
Suplatast (Tosilate)		IL-2		IL-4	IL-5					IL-13							98.33%
Methylthiouracil						IL-6											≥98.0%
(R)-IL-17 modulator 4												IL-17					99.57%
IL-17A modulator-2												IL-17A, pIC₅₀: 8.3					99.07%
Tyrphostin A1									IL-12								98.96%
L6H21						IL-6, IC₅₀: 8.59 μM											99.46%
GIBH-130	IL-1β, IC₅₀: 3.4 nM																99.87%
7,3',4'-Tri-O-methylluteolin	IL-1β					IL-6											99.28%
IL-17A antagonist 3												IL-17A					98.55%
Rosarin	IL-1																99.94%
Anti-inflammatory agent 35						IL-6											99.77%
Satralizumab						IL-6											99.82%
PF-4878691	IL-1β	IL-2				IL-6	IL-8										99.89%
Anti-Mouse IL-10 Antibody (JES5-2A5)								IL-10
Erepdekinra												IL-17					98.60%
Deacetylasperulosidic Acid		IL-2															99.86%
SU5201		IL-2															99.45%
Balsalazide sodium hydrate	IL-1					IL-6											99.61%
Naphazoline nitrate	IL-1β			IL-4		IL-6											≥98.0%
Piperonylic acid						IL-6		IL-10									99.86%
IL-17 modulator 1 disodium												IL-17					99.46%
β-Anhydroicaritin						IL-6		IL-10									99.09%
HMGB1-IN-1	IL-1β																99.37%
RP-54745	IL-1																99.79%
Lys-D-Pro-Thr	IL-1																99.23%
Brazikumab													IL-23, Kd: 0.138 nM
Efineptakin alfa														IL7R
Luteolin-4'-O-glucoside					IL-5												99.05%
Di-O-methyldemethoxycurcumin						IL-6
RO2959 hydrochloride		IL-2
NFAT Transcription Factor Regulator-1		IL-2, IC₅₀: 182 nM															99.37%
Sodium thiocyanate, GR, 99%						IL-6		IL-10									≥99.0%
NO-prednisolone								IL-10									≥99.0%
Anti-Mouse IL-1R Antibody (JAMA-147)	IL-1
Gumokimab												IL-17A
Anti-Mouse IL-1b Antibody (B122)	IL-1
Perakizumab												IL-17A					99.79%
Theophylline (Standard)						IL-6		IL-10									99.99%
IX 207-887	IL-1	IL-2															98.96%
Isoforskolin	IL-1β					IL-6	IL-8										≥98.0%
Negletein	IL-1β, IC₅₀: 10.8 nM																≥99.0%
BML-280	IL-1β						IL-8										99.64%
BAA473	IL-1
Lupeol acetate	IL-1																≥98.0%
IL-2-IN-1		IL-2, IC₅₀: 1978 nM															99.95%
BMS-986251												IL-17, EC₅₀: 24 nM
Veledimex racemate	IL-1																≥98.0%
IL-17 modulator 4 sulfate												IL-17
Elubrixin							IL-8
Efmarodocokin alfa																IL-22
Theophylline monohydrate						IL-6		IL-10
Tagraxofusp			IL-3
A-9758												IL-17A	IL-23
Vopikitug		IL-2
Clazakizumab						IL-6
NLRP3-IN-42	IL-1β
Balsalazide-d₄						IL-6
Lyn peptide inhibitor			IL-3		IL-5
Lck Inhibitor III		IL-2
Coelonin	IL-1β					IL-6
INF 195	IL-1β																99.55%
HSP90-IN-31	IL-1β					IL-6
Triptoquinone B	IL-1
Anti-inflammatory agent 17						IL-6, IC₅₀: 8.254 μM
Hydrangenol						IL-6
IL-17 modulator 6												IL-17, pIC₅₀: 9.1
Y13g						IL-6
Tibulizumab												IL-17A, Kd: 14 pM
Ppc-1		IL-2
NLRP3-IN-24	IL-1β					IL-6
Dectrekumab										IL-13
Abrezekimab										IL-13
Y13g dihydrochloride						IL-6											99.89%
Diacerein (Standard)	IL-1β
ARN14494	IL-1β
Lipoxin A4-d₅							IL-8
TNF-α-IN-10						IL-6
Antiflammin-1	IL-1β
Hidrosmin	IL-1β
CK-119	IL-1
Semapimod	IL-1β					IL-6
IL-17 modulator 1												IL-17
Myelopeptide-2		IL-2
eeAChE-IN-3						IL-6, IC₅₀: 0.57 μM
VEGFR-2-IN-40						IL-6
LM-021	IL-1β					IL-6
Shizukaol B	IL-1β
MR2938	IL-1β					IL-6
Madecassic acid (Standard)	IL-1β					IL-6
JAK1/2-IN-1				IL-4, IC₅₀: 136.5 nM						IL-13, IC₅₀: 19.1 nM
PDE4-IN-8				IL4, IC₅₀: 36.33 nM						IL-13, IC₅₀: 4.04 nM
Theophylline sodium acetate						IL-6		IL-10
IL-1β-IN-1	IL-1β
NLRP3-IN-39	IL-1β
Remtolumab												IL-17A					99.24%
cis-Mulberroside A	IL-1β					IL-6
Immuno modulator-1		IL-2
Lyn peptide inhibitor TFA			IL-3		IL-5
Ac-YVAD-CHO acetate	IL-1β
Naphazoline	IL-1β			IL-4		IL-6
Akt/NF-κB/MAPK-IN-1	IL-1β					IL-6
IL-17A inhibitor 2												IL-17
Sugiol	IL-1β
DPP-4-IN-8	IL-1β					IL-6
RPR-106541				IL-4	IL-5
HPK1-IN-43		IL-2
Veledimex (S enantiomer)	IL-1																99.52%

Name
Email *

	Sorry, but the email address you supplied was invalid.